Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...

Pfizer faces weak growth, sector headwinds, and pipeline uncertainty despite cost cuts and a 7% yield, weighing on sentiment.

Shares of Pfizer Inc. PFE slid 2.18% to $23.29 Thursday, on what proved to be an all-around dismal trading session for the ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 3 clinical study titled ‘MagnetisMM-32’ ...

Genmab (Otc) (($GMAB)) announced an update on their ongoing clinical study. Pfizer Inc. and Genmab are conducting a Phase 4 ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The American multinational biotech firm developed a form of santonin used to treat intestinal worms, which gained rapid ...

Pfizer's (NYSE:PFE) stock up by 7.7% over the past three months. However, we decided to study the company's mixed-bag of ...

I can’t ask you to do that because we are still on the verge of finding out what the Seagen acquisition does. Let’s give Dr.

A former Pfizer Inc. scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid shot data to hurt Donald Trump’s 2020 election prospects, the latest twist ...

(Alliance News) - US pharmaceutical giant Pfizer Inc and German firm BioNTech SE lost Friday a court appeal in the latest step of a multi-million pound battle against US rival Moderna Inc over the ...

This was the stock's third consecutive day of losses.